You are here: Industry Insights > CE Mark

News List

Biomerica’s 15-Minute COVID-19 Antigen Rapid Test Receives CE Mark americanpharmaceuticalreview
January 20, 2021
Biomerica has received CE Mark for its new COVID-19 Rapid Antigen Test for detection of COVID-19 infection. The Company has already received its first European orders and plans to ship the first part of these orders in the coming weeks.
Thermo Fisher Scientific Receives CE Mark for COVID-19 Test americanpharmaceuticalreview
April 01, 2020
Thermo Fisher Scientific has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19.
Polyganics Achieves CE Mark Certification for LIQOSEAL® b3cnewswire
January 16, 2020
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced today that it has obtained CE marking for LIQOSEAL®, its easy-to-use and innovative dural sealant patch ...
Neurolief receives CE mark for Relivion biospectrumasia
July 10, 2019
The Relivion is the first non-invasive, adaptive multi-channel brain neuromodulation technology that offers a highly effective therapy, without the risks and costs associated with invasive procedures and without the side effects related to medications.
Advent Access receives CE Mark for av-Guardian Vascular Access System biospectrumasia
July 04, 2019
The world's first implant technology to facilitate dialysis needles to optimally access the dialysis vein without the implant being in contact with the vein in patients undergoing hemodialysis.
Ortho's VITROS® XT MicroSlide receives CE Mark biospectrumasia
March 19, 2019
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced it has received CE Mark for Ortho’s VITROS® XT MicroSlide, a new multi-test technology that allows labs to run two tests simultaneously.
XACT Robotics nets CE mark, $5M for its robot-guided needle surgery system fiercebiotech
September 18, 2018
The company plans to set up seven centers of excellence in the U.S., Europe and Israel ahead of the full launch next year.
Insulia Receives FDA Clearance, CE Mark to Integrate Basaglar, Tresiba americanpharmaceuticacreview
November 17, 2017
Voluntis announced that Insulia, its digital companion for people with Type 2 diabetes, has received FDA clearance and the CE mark to integrate Basaglar and Tresiba.
Abbott announces CE Mark and first use of the world's first smartphone compatible insertable cardiac worldpharmanews
May 09, 2017
Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fib
BTG receives CE mark certification for radiopaque drug-eluting bead europeanpharmaceuticalreview
April 07, 2017
BTG, a global specialist healthcare company, has received Class III CE Mark certification for DC Bead LUMI, the first commercially available radiopaque drug-eluting bead (DEB) in the EU which can be loaded with doxorubicin or irinotecan.